67 related articles for article (PubMed ID: 25160192)
1. Estimating the impact of prevention action: a simulation model of cervical cancer progression.
Rosen-Zvi M; Shpigelman L; Kalton A; Weissbrod O; Akindeinde S; Benefeldt S; Bentley A; Everett T; Jajinskiji J; Kweyu E; Neti C; Saab J; Stewart O; Ward M; Xie GT
Stud Health Technol Inform; 2014; 205():288-92. PubMed ID: 25160192
[TBL] [Abstract][Full Text] [Related]
2. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
3. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
4. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center data.
Stock EM; Stamey JD; Sankaranarayanan R; Young DM; Muwonge R; Arbyn M
Cancer Epidemiol; 2012 Apr; 36(2):153-60. PubMed ID: 21856264
[TBL] [Abstract][Full Text] [Related]
5. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
Coupé VM; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
Vaccine; 2009 Aug; 27(37):5111-9. PubMed ID: 19567242
[TBL] [Abstract][Full Text] [Related]
6. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.
Sancho-Garnier H; Khazraji YC; Cherif MH; Mahnane A; Hsairi M; El Shalakamy A; Osgul N; Tuncer M; Jumaan AO; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G51-7. PubMed ID: 24331820
[TBL] [Abstract][Full Text] [Related]
7. Explicit evidence for prognostic Bayesian network models.
Yet B; Perkins Z; Tai N; Marsh W
Stud Health Technol Inform; 2014; 205():53-7. PubMed ID: 25160144
[TBL] [Abstract][Full Text] [Related]
8. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
9. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian model for estimating multi-state disease progression.
Shen S; Han SX; Petousis P; Weiss RE; Meng F; Bui AA; Hsu W
Comput Biol Med; 2017 Feb; 81():111-120. PubMed ID: 28038345
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
13. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
[No Abstract] [Full Text] [Related]
14. Variational bayesian blind deconvolution using a total variation prior.
Babacan SD; Molina R; Katsaggelos AK
IEEE Trans Image Process; 2009 Jan; 18(1):12-26. PubMed ID: 19095515
[TBL] [Abstract][Full Text] [Related]
15. On the relationship between dependence tree classification error and Bayes error rate.
Balagani KS; Phoha VV
IEEE Trans Pattern Anal Mach Intell; 2007 Oct; 29(10):1866-8. PubMed ID: 17699930
[TBL] [Abstract][Full Text] [Related]
16. Wavelet-based Bayesian image estimation: from marginal and bivariate prior models to multivariate prior models.
Tan S; Jiao L; Kakadiaris IA
IEEE Trans Image Process; 2008 Apr; 17(4):469-81. PubMed ID: 18390356
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
18. Advancing cervical cancer prevention in India: implementation science priorities.
Krishnan S; Madsen E; Porterfield D; Varghese B
Oncologist; 2013; 18 Suppl():13-25. PubMed ID: 24334478
[TBL] [Abstract][Full Text] [Related]
19. Speckle suppression in SAR images using the 2-D GARCH model.
Amirmazlaghani M; Amindavar H; Moghaddamjoo A
IEEE Trans Image Process; 2009 Feb; 18(2):250-9. PubMed ID: 19126469
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel.
Schejter E; Bornstein J; Siegler E
Vaccine; 2013 Nov; 31 Suppl 8():I42-5. PubMed ID: 24229718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
